Health Condition 1: J453- Mild persistent asthma
Conditions
Interventions
Intervention1: Habb-e-Filfil
: 2 tab Twice Daily with water
For 4 weeks.
Control Intervention1: NIL: NIL
Sponsors
Central Council for Research in Unani Medicine CCRUM New Delhi
Eligibility
Inclusion criteria
Inclusion criteria: 1. Mild and moderate cases of Bronchial Asthma (according to The Global Initiative for Asthma Classification) presenting with at least one of the following symptoms: .Wheeze .Shortness of breath .Chest tightness and cough that vary over time and in intensity. 2.Participants with FEV1 between 60%-80%
Exclusion criteria
Exclusion criteria: 1. Severe case of Bronchial asthma FEV1 BY less than 60% 2. known case of Interstitial lung disease. 3. known cases of chronic obstructive pulmonary disease (COPD). 4. Patient with regular use of oral or systemic corticosteroids for conditions other than Asthma. 5. Participants with other Respiratory Tract Infections, tuberculosis and malignancy. 6. Patients with diseases requiring long term treatment. 7. Patients with Mental disorders affecting drug compliance. 8.Participants with Tobacco Smoking. 9. Pregnant and lactating females.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The efficacy of the study drug in the treatment of mild to moderate Zeeq un Nafas (Bronchial Asthma) will be carried out on the basis of Asthma Control Questionnaire (ACQ) and AQLQ (Asthma Quality of Life Questionnaire with standard activities)Timepoint: Weekly | — |
Secondary
| Measure | Time frame |
|---|---|
| Haematological and biochemical investigations for safety assessment i.e., Hemogram, LFT, KFT and Urine Examination: Routine & Microscopic.Timepoint: At baseline and at the end of treatment.i.e., 0 and 4th week | — |
Countries
India
Contacts
Public ContactDr Pradeep Kumar
Central Council for Research in Unani Medicine (CCRUM)
Outcome results
None listed